Jenny Yao

2.1k total citations · 2 hit papers
13 papers, 1.5k citations indexed

About

Jenny Yao is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jenny Yao has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jenny Yao's work include Angiogenesis and VEGF in Cancer (3 papers), Cancer Research and Treatments (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Jenny Yao is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cancer Research and Treatments (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Jenny Yao collaborates with scholars based in United States, China and United Kingdom. Jenny Yao's co-authors include Napoleone Ferrara, Carlos Bais, Xiumin Wu, Guanglei Zhuang, Ian Kasman, Deepak Sampath, Zhaoshi Jiang, Yinghui Guan, Jason Oeh and Zora Modrušan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Jenny Yao

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

2007 522 citations Farbod Shojaei, Xiumin Wu et al. Nature profile →
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity

2020 295 citations Dylan Richards, Yang Li et al. Nature Biomedical Engineering profile →

Peers

Countries citing papers authored by Jenny Yao

Since Specialization

Citations

This map shows the geographic impact of Jenny Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Yao more than expected).

Fields of papers citing papers by Jenny Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Yao. The network helps show where Jenny Yao may publish in the future.

Co-authorship network of co-authors of Jenny Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Yao. A scholar is included among the top collaborators of Jenny Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Yao. Jenny Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Abstract 5977: A first-in-human, open-label, multi-center phase 1 study of TST003, a GREM 1 inhibitor, in subjects with locally advanced or metastatic solid tumors 2024 ·Cancer Research ·(unknown), Lin Shen, Shivaani Kummar, Minal Barve, Caroline Germa, (unknown), Lei Chen, (unknown), Jenny Yao, (unknown), (unknown)	3
2	A phase 1, first-in-human, open-label, dose escalation and dose expansion study of TST005 in patients with locally advanced or metastatic solid tumors. 2023 ·Journal of Clinical Oncology ·Anthony W. Tolcher, Xiaohua Wu, Jian Zhang, Minal Barve, Nashat Gabrail, David Sommerhalder, (unknown), Sharon Wilks, Yong Wu, Rujiao Liu, Shuiping Gao, (unknown), (unknown), Caroline Germa, (unknown), (unknown), Steven Yu, Jenny Yao, Xuelian Zhu	5
3	TST001 (a high affinity humanized anti-claudin18.2 monoclonal antibody) in combination with nivolumab plus capecitabine and oxaliplatin as first-line or with nivolumab as late-line treatment in locally advanced and metastatic gastric/gastroesophageal junction (G/GEJ) cancer: Design of cohorts from a phase I/IIa study (TST001-1002). 2023 ·Journal of Clinical Oncology ·Weijian Guo, Caroline Germa, (unknown), (unknown), Jenny Yao, Jianming Wang, Lijuan Zhang, Xueming Qian, (unknown)	3
4	A small molecule inhibitor prevents gut bacterial genotoxin production 2022 ·Nature Chemical Biology ·(unknown), (unknown), Martin Daniel-Ivad, Jenny Yao, Alessia Stornetta, Peter W. Villalta, Hsin‐Che Huang, Daniel A. Bachovchin, Silvia Balbo, Rachelle Gaudet, Emily P. Balskus	22
5	Characterization of a rapid condensate collection apparatus for in vitro assays of electronic nicotine delivery systems 2022 ·Toxicology in Vitro ·Guy Lalonde, (unknown), Jenny Yao, Russell L. Wolz, (unknown), I. Gene Gillman, Michael J. Oldham	5
6	A noninvasive fluorescence imaging-based platform measures 3D anisotropic extracellular diffusion 2021 ·Nature Communications ·(unknown), Xun Chen, (unknown), Brooke J. Damon, Changcheng Shi, Jenny Yao, Matthew C. Coombs, Michael Kern, Tong Ye, Hai Yao	22
7	Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity breakdown → 2020 ·Nature Biomedical Engineering ·Dylan Richards, Yang Li, Charles M. Kerr, Jenny Yao, Gyda Beeson, Robert C. Coyle, Xun Chen, Jia Jia, Brooke J. Damon, Robert Wilson, E. Starr Hazard, Gary Hardiman, Donald R. Menick, Craig C. Beeson, Hai Yao, Tong Ye, Ying Mei	295
8	The Effects of Metabolic Substrate Availability on Human Adipose-Derived Stem Cell Spheroid Survival 2018 ·Tissue Engineering Part A ·Robert C. Coyle, Jenny Yao, Dylan Richards, Ying Mei	21
9	Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids 2017 ·Acta Biomaterialia ·Yu Jun Tan, Dylan Richards, Robert C. Coyle, Jenny Yao, Ruoyu Xu, Wenyu Gou, Hongjun Wang, Donald R. Menick, Bozhi Tian, Ying Mei	36
10	Phosphoproteomic Analysis Implicates the mTORC2-FoxO1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases 2013 ·Science Signaling ·Guanglei Zhuang, Kebing Yu, Zhaoshi Jiang, Alicia S. Chung, Jenny Yao, Connie Ha, Karen Toy, Robert Soriano, Benjamin Haley, Elizabeth Blackwood, Deepak Sampath, Carlos Bais, Jennie R. Lill, Napoleone Ferrara	60
11	Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway 2012 ·The EMBO Journal ·Guanglei Zhuang, Xiumin Wu, Zhaoshi Jiang, Ian Kasman, Jenny Yao, Yinghui Guan, Jason Oeh, Zora Modrušan, Carlos Bais, Deepak Sampath, Napoleone Ferrara	403
12	Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy 2011 ·Proceedings of the National Academy of Sciences ·Jenny Yao, Xiumin Wu, Guanglei Zhuang, Ian Kasman, (unknown), Vernon T. Phan, Masabumi Shibuya, Napoleone Ferrara, Carlos Bais	81
13	Bv8 regulates myeloid-cell-dependent tumour angiogenesis breakdown → 2007 ·Nature ·Farbod Shojaei, Xiumin Wu, Cuiling Zhong, Lanlan Yu, Xiao‐Huan Liang, Jenny Yao, Dominique Blanchard, Carlos Bais, Franklin Peale, Nicholas van Bruggen, Calvin Ho, Jed Ross, (unknown), Richard A.D. Carano, Y. Gloria Meng, Napoleone Ferrara	522

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact